SEC Form S-1/A filed by East Resources Acquisition Company (Amendment)
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - Abacus Life, Inc. (0001814287) (Issuer)
4 - Abacus Life, Inc. (0001814287) (Issuer)
4 - Abacus Life, Inc. (0001814287) (Issuer)
4 - Abacus Life, Inc. (0001814287) (Issuer)
4 - Abacus Life, Inc. (0001814287) (Issuer)
ERES Shareholders Approved the Business Combination on June 29, 2023 Abacus Life to begin trading on Nasdaq on July 5, 2023 under ticker symbol "ABL" East Resources Acquisition Company (NASDAQ:ERES) ("ERES"), a publicly traded special purpose acquisition company, today announced the completion of its business combination with Abacus Life, a leading buyer of life insurance policies and a vertically integrated alternative asset manager specializing in specialty insurance products. ERES shareholders voted to approve the business combination at a meeting held on June 29, 2023. In connection with the completion of the business combination, ERES has been renamed "Abacus Life, Inc." ("Abacus
Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, will participate in a virtual fireside chat with The Palm Beach Hedge Fund Association and IPO Edge Friday, June 23, 2023 at 9:00am ET. The live event will feature Abacus President and CEO, Jay Jackson and will be moderated by IPO Edge Editor-in-Chief John Jannarone who will discuss: Abacus' business combination with East Resources Acquisition Company (NASDAQ:ERES); Current ownership structure and growth story; Abacus' business
Abacus Pays 11% More per Policy Than its Closest Competitor Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that according to financial publication The Deal, the Company continued to expand its market share in the life settlement industry and remained a leader in life settlement payouts in 2022, bringing premier value to its clients. The Deal report evaluates life settlement providers based on the number of policies purchased and value. For 2022, while the life settl
8-K - Abacus Life, Inc. (0001814287) (Filer)
8-K - Abacus Life, Inc. (0001814287) (Filer)
8-K - Abacus Life, Inc. (0001814287) (Filer)
Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced that Nicholas Sawuk has joined the Company as Managing Director. Sawuk brings nearly 20 years of experience in financial services and life settlements and has worked for companies such as a European Life Settlement Fund with its own life settlement provider, as well as Cantor Fitzgerald on Cantor Insurance Group's life settlement and insurance-linked securities desk in New York. Most recently, Sawuk served as the of Head
- Abacus Life and East Resources Acquisition Company (NASDAQ:ERES) enter business combination agreement - Sector leader within an uncorrelated alternative asset class with a $233 billion TAM, institutional investment grade counterparts and outsized growth potential, underpinned by steady financial performance - Proprietary technology platform yields differentiated underwriting capabilities - Transaction implies pro-forma enterprise value of $618 million; proceeds to be used to reduce cost of capital, scale hold portfolio and begin securitizing policy portfolios - Anticipated transaction close as early as the fourth quarter of 2022 - Combined company's shares of common stock expected to
SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)
SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)
SC 13D/A - Abacus Life, Inc. (0001814287) (Subject)